Three Year Treatment Patterns of Ranibizumab and Aflibercept for The Management of Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in The USA
Abstract
Authors
C Leteneux F Milnes A Skelly V Bezlyak E Paschen A Sagkriotis